Literature DB >> 5774267

Methylandrostenediol hypertension induced without salt excess: observations on organ changes and serum composition.

C E Hall, O Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5774267      PMCID： PMC2013481     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  13 in total

1.  CORONARY ATHEROSCLEROSIS. I. CONTRAST OF DOCA HYPERTENSION WITH RENAL HYPERTENSION IN THE ETIOLOGY OF CORONARY ATHEROSCLEROSIS IN THE ADULT MALE WISTAR RAT.

Authors:  C H EADES; G E PHILLIPS; A BLAUSTEIN; I C HSU; V B SOLBERG
Journal:  Angiologica       Date:  1965

2.  Effects of renin in rats treated with methylandrostenediol.

Authors:  G M MASSON; E R FISHER; A C CORCORAN; I H PAGE
Journal:  Endocrinology       Date:  1955-05       Impact factor: 4.736

3.  Interrelationship of electrolytes, juxtaglomerular cells and hypertension.

Authors:  L TOBIAN
Journal:  Physiol Rev       Date:  1960-04       Impact factor: 37.312

4.  Role of salt and renal mass in experimental hypertension.

Authors:  S KOLETSKY
Journal:  AMA Arch Pathol       Date:  1959-07

5.  The effect of 17-methylandrostenediol on the secretory capacity of the adrenal cortex of rats.

Authors:  M SAFFRAN; M VOGT
Journal:  J Physiol       Date:  1960-04       Impact factor: 5.182

6.  Experimental hypertensive vascular disease in the rat; a histopathologic study of the lesions produced by methylandrostenediol and desoxycorticosterone acetate.

Authors:  F R SKELTON
Journal:  AMA Arch Pathol       Date:  1955-08

7.  The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat.

Authors:  E SALGADO; H SELYE
Journal:  Endocrinology       Date:  1954-11       Impact factor: 4.736

8.  The role of the thyroid in the production of cardiovascular and renal changes by methylandrostenediol.

Authors:  E SALGADO; H SELYE
Journal:  J Endocrinol       Date:  1954-11       Impact factor: 4.286

9.  The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat.

Authors:  F R SKELTON
Journal:  Endocrinology       Date:  1953-11       Impact factor: 4.736

10.  The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat.

Authors:  F B BYROM
Journal:  Lancet       Date:  1954-07-31       Impact factor: 79.321
View more
  1 in total

1.  Irreversibility of methylandrostenediol-induced hypertension in the rat after suspension of the androgen treatment.

Authors:  A Molteni; A C Brownie; P A Nickerson; F R Skelton
Journal:  Am J Pathol       Date:  1972-10       Impact factor: 4.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.